FIELD: medicine. SUBSTANCE: method involves administering agglutinating pertussis serum to experimental animals at a single intraperitoneal dose of 0.10 ml. EFFECT: simplified method; improved reproducibility. 6 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING ANTI-WHOOPING VACCINE IMMUNOGENICITY | 2003 |
|
RU2231793C1 |
METHOD FOR EVALUATING PERTUSSIS VACCINE TOXICITY | 1999 |
|
RU2174229C2 |
METHOD FOR EVALUATING WOOPING COUGH VACCINE TOXICITY | 2001 |
|
RU2227293C2 |
METHOD OF PROTECTIVE WHOOPING COUGH ANTIGEN PREPARING | 1999 |
|
RU2148412C1 |
METHOD OF IMMUNIZATION WITH BACTERIAL PREPARATIONS CONTAINING ENDOTOXIN | 0 |
|
SU1306582A1 |
METHOD OF SIMULATING SECONDARY IMMUNODEFFICIENT CONDITION | 0 |
|
SU1476517A1 |
IMMUNOSTIMULATING AGENT | 1993 |
|
RU2077339C1 |
METHOD OF PREPARING PERTUSSOID ANTIGEN COMPLEX | 1990 |
|
SU1767975A1 |
MEDICATION POSSESSING IMMUNOTROPIC ACTIVITY | 2009 |
|
RU2406524C1 |
METHOD OF SIMULATING IMMUNODEFICIENT CONDITION IN EXPERIMENTAL ANIMALS | 1996 |
|
RU2123702C1 |
Authors
Dates
1995-12-10—Published
1992-10-16—Filed